South African approval26 Jan 2021 23:30
30 September rns
Genedrive® 96 SARS-CoV-2 Kit approved in South Africa
genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that the Company's Genedrive® 96 SARS-CoV-2 Kit has received approval from the South African Health Products Regulatory Authority. The Genedrive® kit was submitted for evaluation in June 2020.
Under the approval, the Kit can now be distributed and sold within South Africa. Genedrive products are supplied in the country, and more broadly within Africa, via the Sysmex EMEA organisation.